Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GE HealthCare Technologies (GEHC) Invested Capital (2022 - 2025)

GE HealthCare Technologies' Invested Capital history spans 4 years, with the latest figure at $20.4 billion for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital rose 17.04% year-over-year to $20.4 billion, compared with a TTM value of $20.4 billion through Dec 2025, up 17.04%, and an annual FY2025 reading of $20.4 billion, up 17.04% over the prior year.
  • Invested Capital for Q4 2025 was $20.4 billion at GE HealthCare Technologies, roughly flat from $20.3 billion in the prior quarter.
  • The five-year high for Invested Capital was $20.4 billion in Q4 2025, with the low at $6.9 billion in Q1 2023.
  • Average Invested Capital over 4 years is $15.9 billion, with a median of $17.1 billion recorded in 2022.
  • Year-over-year, Invested Capital crashed 58.49% in 2023 and then soared 160.83% in 2024.
  • Tracing GEHC's Invested Capital over 4 years: stood at $17.6 billion in 2022, then fell by 5.81% to $16.6 billion in 2023, then increased by 4.99% to $17.4 billion in 2024, then grew by 17.04% to $20.4 billion in 2025.
  • Per Business Quant, the three most recent readings for GEHC's Invested Capital are $20.4 billion (Q4 2025), $20.3 billion (Q3 2025), and $20.0 billion (Q2 2025).